Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Samidorphan

Drug Profile

Samidorphan

Alternative Names: ALKS 33; RDC-0313; RDC-0313-00

Latest Information Update: 03 Jun 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rensselaer Polytechnic Institute
  • Developer Alkermes; Alkermes plc
  • Class Amides; Cyclopropanes; Drug withdrawal therapies; Morphinans; Small molecules
  • Mechanism of Action Opioid mu receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Alcoholism; CNS disorders; Eating disorders; Substance-related disorders

Most Recent Events

  • 07 Nov 2019 Ad-hoc task: Indication change from Drug abuse to Substance-related disorders - replaced the indication Drug abuse with Substance-related disorders in the Intro and HEs
  • 17 Dec 2015 No development reported - Phase-I for CNS disorders (In volunteers) in USA (PO)
  • 17 Dec 2015 No development reported - Phase-I for Substance-related disorders (In volunteers) in USA (PO)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top